ClinConnect ClinConnect Logo
Search / Trial NCT05270434

Optimal Timing of Endoscopic Intervention in the Treatment of Chronic Pancreatitis.

Launched by CHANGHAI HOSPITAL · Mar 7, 2022

Trial Information

Current as of June 27, 2025

Enrolling by invitation

Keywords

Extracorporeal Shock Wave Lithotripsy(eswl) Chronic Pancreatitis Endoscopic Retrograde Cholangiopancreatography(ercp) Pancreatic Stones

ClinConnect Summary

Chronic pancreatitis(CP)is a chronic progressive fibro-inflammatory disease of the pancreas induced by a wide range of factors including genetic and environmental elements, with recurrent abdominal pain and pancreatic secretion insufficiency as its major clinical signs. Chronic pancreatitis is not only a tough disease of the gastrointestinal system but also a worldwide medical problem. At present, the MESS (medicine-extracorporeal shock wave lithotripsy-endoscopic retrograde cholangiopancreatography-surgery)formed by changhai hospital in CP diagnosis and treatment is gradually becoming matu...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. symptomatic adult patients diagnosed with chronic pancreatitis and main pancreatic duct positive stones(\>5mm in diameter)
  • 2. no ERCP and ESWL history before the admission
  • 3. provides informed consent
  • Exclusion Criteria:
  • 1. suspected to have malignant tumors;
  • 2. history of pancreatic surgery or gastrojejunostomy (Billroth II);
  • 3. with end-stage disease;
  • 4. with contraindications to ESWL or ERCP, such as pregnancy, abdominal aortic aneurysm, etc.
  • 5. acute pancreatitis within 3 days
  • 6. pancreatic ascites

About Changhai Hospital

Changhai Hospital is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence, the hospital integrates cutting-edge medical technologies and a multidisciplinary approach to patient care. Changhai Hospital actively collaborates with research organizations and healthcare professionals to conduct rigorous clinical trials aimed at developing new treatments and improving patient outcomes. By prioritizing patient safety and ethical standards, the hospital plays a pivotal role in contributing to the advancement of medical knowledge and the enhancement of therapeutic options.

Locations

Shanghai, , China

Patients applied

0 patients applied

Trial Officials

Zhuan Liao, MD

Principal Investigator

Changhai Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials